P108
Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory DiseaseStudy of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple MyelomaPhase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant
P767
description
amerikanische Non-Profit-Organisation
@de
non-profit organisation in the USA
@en
name
Multiple Myeloma Research Foundation
@en
Multiple Myeloma Research Foundation
@fr
type
label
Multiple Myeloma Research Foundation
@en
Multiple Myeloma Research Foundation
@fr
prefLabel
Multiple Myeloma Research Foundation
@en
Multiple Myeloma Research Foundation
@fr
P214
P244
P3153
P6366
P1297
06-1504413
P131
P1454
P213
0000 0000 9350 5788
P2139
36,113,277
P214
P2427
grid.429426.f
P244
n2001127878
P3153
P3500
P571
1998-01-01T00:00:00Z
P6366
2802474972
P6782
P7859
lccn-n2001127878